GuruFocus.com via Yahoo Finance
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
5 hours ago
Simply Wall St. via Yahoo Finance
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given...
6 hours ago
Zacks
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
13 hours ago
Reuters via Yahoo Finance
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
7 hours ago
US News & World Report
Regeneron Misses Profit Estimates on Weaker Eylea and Dupixent Sales
Morningstar
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales
ETF DAILY NEWS
Cwm LLC Sells 256 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
6 days ago
Investing.com
EYLEA HD shows promise in long-term clinical trials By Investing.com
3 days ago
RWA Wealth Partners LLC Invests $375,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Knox Daily
Checking in on Regeneron Pharmaceuticals, Inc.
1 day ago
regeneron.com
More on Yahoo Finance